Shuji Sato

Shuji Sato has extensive experience in the field of antibody discovery and engineering. They have held various roles in reputable companies such as IPA, Dragonfly Therapeutics, Pfizer, and Bluefin BioMedicine, where they were involved in leading antibody technology teams and managing biologics development projects. They have also worked as a Scientific Consultant and conducted international travel for self-exploration. Most recently, Shuji Sato served as the Senior Director of Client Relations at IPA, representing the company in Europe and North America. Their career progression showcases a strong background in the biotechnology and pharmaceutical industries.

Shuji Sato earned a Bachelor of Arts (B.A.) from Brandeis University in 1995. Shuji then went on to receive a Ph.D. in Molecular Microbiology from Tufts University School of Medicine in 2004.